脑部放疗，上午比下午敏感许多！2 m) _- I: J' f- R
; ?- k( u. b+ d' m
8 p: W6 _1 M- \8 X) F1 LCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9. ?4 V9 h4 P( b/ O
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?4 h: t: t) Q1 m. w, e- d
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
v% m- Z+ @- } k% U, l$ HSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.; h. U, o; j1 i6 r) d
: b* Z: o! c4 y- w
Abstract
; R# n8 }: p8 Z& s4 Z" U% _BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
! [6 x6 Y" D6 G, b8 J$ O
0 ~* m( @2 q. f5 F H& }: l6 ~METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
% ?) i3 _: ]; i5 S6 H% @& {; n0 l- m* Q( Z' r6 H& K# p" R
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
~. P3 v: k q8 S' H
# U( O+ `6 T" y G3 M& m ECONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.2 F& F8 A: y) T8 x4 w) A* m: Q1 }
* ?/ j# Z, O0 S$ N8 |5 c5 W3 G; | |
. A2 r2 P, I+ q% u% s3 t
显身卡
